$ETON News

Eton Pharmaceuticals Submits FDA Prior Approval Supplement For Its New Formulation Of KHINDIVI Oral Solution

Craig-Hallum Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $62

Canaccord Genuity Initiates Coverage On Eton Pharmaceuticals with Buy Rating, Announces Price Target of $60

Eton Pharma Enters Into Supply And Distribution Agreement For US Commercialization Rights To IMPAVIDO From Affiliate Of Knight Therapeutics

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Raises Price Target to $57

Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ...

Eton Pharmaceuticals Q1 Earnings Call Highlights

Eton Pharmaceuticals, Inc. (ETON) Misses Q1 Earnings Estimates

Eton Pharmaceuticals, Inc. (ETON) Q1 2026 Earnings Call Transcript

Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance

Eton Pharmaceuticals Reports First Quarter 2026 Financial Results

Full Transcript: Eton Pharmaceuticals Q1 2026 Earnings Call

Eton Pharmaceuticals FY2026 Revenue expected to be more than $120.000M vs $113.804M Est

Eton Pharmaceuticals Q1 Adj. EPS $0.14 Beats $0.09 Estimate, Sales $24.266M Beat $22.312M Estimate

Eton Pharmaceuticals to Participate in Upcoming Investor Conferences

Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Lags Revenue Estimates

Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

How The Hemangeol Deal Is Rewriting The Story For Eton Pharmaceuticals (ETON)

Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution